当前位置:首页 - 行情中心 - 博力威(688345) - 财务分析 - 利润表

博力威

(688345)

  

流通市值:17.66亿  总市值:17.66亿
流通股本:1.00亿   总股本:1.00亿

利润表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、营业总收入1,275,704,907.36829,178,418.28357,720,738.52,234,529,429.09
营业收入1,275,704,907.36829,178,418.28357,720,738.52,234,529,429.09
二、营业总成本1,301,736,754.18847,164,830.19372,585,906.942,196,981,897.08
营业成本1,063,772,997.98690,519,442.8297,014,746.031,882,253,926.01
税金及附加13,532,287.0710,662,798.46,172,119.952,548,642.03
销售费用50,126,198.6231,480,857.6615,918,928.672,382,319.45
管理费用70,368,650.148,976,565.8323,334,452.9799,934,442.16
研发费用96,770,124.3263,446,274.0129,982,076.68133,373,777.64
财务费用7,166,496.092,078,891.49163,582.716,488,789.79
其中:利息费用11,306,668.067,290,107.143,249,286.3815,417,695.95
其中:利息收入2,264,425.691,576,236.48964,970.636,527,242.28
加:公允价值变动收益-3,035,550-3,081,750-2,578,100-17,933,299
加:投资收益663,507.16948,375.33-342,629.25298,633.1
资产处置收益-868,615.13-869,860.05-133,060.44-3,713,964.62
资产减值损失(新)-18,214,191.43-16,898,724.09-14,148,765.32-66,113,882.23
信用减值损失(新)-4,700,758.7-6,027,296.681,624,775.04-7,836,347.41
其他收益7,567,966.744,681,028.7658,512.317,223,846.91
营业利润平衡项目0000
四、营业利润-44,619,488.18-39,234,638.7-29,784,436.1-50,527,481.24
加:营业外收入379,466.85338,264.45219,131.3558,454.05
减:营业外支出569,151.44477,507.51206,806.0313,451,178.64
利润总额平衡项目0000
五、利润总额-44,809,172.77-39,373,881.76-29,772,110.78-63,920,205.83
减:所得税费用-22,418,283.9-16,801,171.88-9,119,502.85-30,139,982.52
六、净利润-22,390,888.87-22,572,709.88-20,652,607.93-33,780,223.31
持续经营净利润-22,390,888.87-22,572,709.88-20,652,607.93-33,780,223.31
归属于母公司股东的净利润-22,390,888.87-22,572,709.88-20,652,607.93-33,780,223.31
(一)基本每股收益-0.22-0.23-0.21-0.34
(二)稀释每股收益-0.22-0.23-0.21-0.34
八、其他综合收益-3,759,585.61-8,444,761.62-9,125,680.0715,936,349.48
归属于母公司股东的其他综合收益-3,759,585.61-8,444,761.62-9,125,680.0715,936,349.48
九、综合收益总额-26,150,474.48-31,017,471.5-29,778,288-17,843,873.83
归属于母公司股东的综合收益总额-26,150,474.48-31,017,471.5-29,778,288-17,843,873.83
归属于少数股东的综合收益总额---0
公告日期2024-10-292024-08-242024-04-202024-04-20
审计意见(境内)标准无保留意见
TOP↑